- Oral presentation
- Open Access
Human pluripotent stem cell process parameter optimization in a small scale suspension bioreactor
© Lipsitz and Zandstra 2015
- Published: 14 December 2015
- Aggregate Size
- HES2 Cell
- Rock Inhibitor
- Human Pluripotent Stem Cell
- HES2 Cell Line
As cell-based therapies begin to enter clinical trials, human pluripotent stem cells (PSCs) present a reliable and robust source of cells for differentiation into all cell types in the human body. PSC may one day provide cells for new treatment options for a wide range of diseases including cardiovascular disease, neurodegenerative diseases, and diabetes. The large numbers of cells required for many of these therapies necessitates the development of scalable and cost efficient technologies for manufacturing PSCs and their derivatives . PSCs are an adherent cell type that is susceptible to phenotypic change in response to environmental stress. Adherent PSCs can be grown in suspension by forming aggregates of undifferentiated cells[3, 4], by encapsulating PSCs in beads or hydrogels[5, 6], or by adhering PSCs to the surface of microcarriers[7, 8].
Most PSC suspension expansion to date has been performed in benchtop stirred-tank bioreactors operating at volumes of 50-200mL. Little bioprocess optimization has been conducted at these scales likely because of the high cost of PSC growth media and labour requirements for bioreactor growth. This study describes the use of a small-scale bioreactor system for Design-of-Experiments based PSC expansion process development. These process developments inform strategies to bring PSC-based processes into clinical production.
Human embryonic stem cells (HES2 cell line) were cultured in adherent conditions on Geltrex-coated plates. Cells were fed daily with Nutristem PSC XF Media, and were passaged with TrypLE every 5-6 days at a passage ratio of 1:24. Cells were dissociated to single cells for bioreactor seeding with TrypLE, strained through a 40μm strainer, and seeded into Nutristem media with Y-27632 ROCK inhibitor prior to bioreactor seeding. Culture media was exchanged at regular intervals by allowing aggregates to settle, removing half of the culture media, and replacing fresh media (without ROCK inhibitor).
Preliminary results indicated that ROCK inhibitor is essential for cell survival and expansion (data not shown). Cell expansion was strongly dependent on feeding frequency (Figure 1c): daily cell feeding resulted in significantly higher cell densities. Seeding density also significantly influenced cell expansion (Figure 1c) with both higher and lower densities producing higher cell expansion than intermediate densities. The optimal cell density found in this experiment, 2x105cells/mL, was an endpoint within the experimental conditions tested; however, when testing a lower cell density (1x105 cells/mL), cells formed large aggregates with low cell viability (data not shown). Fold-increase in cell numbers was plotted against the significant input parameters (Figure 1d) to depict the surface response in this experiment. The curvature of the surface response is characteristic of the quadratic parameters that were significant in the regression of the experimental data. Significant interaction effects were observed between seeding density and feeding frequency (Figure 1c).
The final composition of PSCs in the bioreactor-expanded cells was quantified by flow cytometry. All conditions tested retained >90% Oct4+ Nanog+ pluripotent PSCs (representative plot in Figure 1e) after six days of bioreactor culture.
PSC were observed to spontaneously form uniform aggregates when seeded into the bioreactor as single cells, which expanded to uniform PSCs aggregates at 4 and 6 days of expansion (Figure 1f and representative images in Figure 1g). Aggregate size was found to also be a function of feeding frequency (Figure 1f), and was correlated with final fold increase in cell number. Frequent feeding resulted in increased variability in aggregate size (Figure 1f).
The process optimum found in this study raises several interesting questions for future experimentation. The most significant factor was feeding frequency, with more frequent feeding increasing yields; however, it is unknown what drives the dramatic effects of media supplementation on the resultant increased yields. If growth factors are being depleted, repeating these experiments with culture media that is more enriched in the necessary growth factors could generate different trends than those observed here. Similarly, if secreted factors or metabolites impede cell growth, modified media exchange strategies may be appropriate.
While the initial experimental design investigated the effects of oxygen tension on cell production, this parameter was found to be insignificant in these studies. Previous literature indicates that hypoxic conditions are beneficial for PSC growth , as well as the expansion of various other stem cell types[10, 11]. In our experiment, cells were not previously adapted to hypoxic conditions, which may impact cell responses during oxygen dependence transitions and limited the observed significance of this parameter. Alternatively, the dissolved oxygen setpoint in the hypoxic condition may have been too high to observe beneficial growth due to differences in mass transfer between the Micro-24 system used and systems used by others.
For future experimentation, the effects of increasing culture volume and the resulting effects on the shear stress that cells are exposed to should be explored. Not only will this increase understanding of bioprocess parameters in this platform, but increasing cell volume above the 2mL point, which is the low end of the operating range of the device, could decrease experimental variability.
The Micro-24 system represents a tool useful for relating media components, cellular parameters, and bioprocess parameters to cell manufacturing in the cell therapy industry. The results of this experiment can guide the development of process design spaces for PSC expansion processes.
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282 (5391): 1145-1147.PubMedView ArticleGoogle Scholar
- Kirouac DC, Zandstra PW: The Systematic Production of Cells for Cell Therapies. Cell stem cell. 2008, 3 (4): 369-381.PubMedView ArticleGoogle Scholar
- Amit M, Laevsky I, Miropolsky Y, Shariki K, Peri M, Itskovitz-Eldor J: Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc. 2011, 6 (5): 572-579.PubMedView ArticleGoogle Scholar
- Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U: Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc. 2011, 6 (5): 689-700.PubMedView ArticleGoogle Scholar
- Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A: The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials. 2008, 29 (29): 3946-3952.PubMedView ArticleGoogle Scholar
- Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW: Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004, 22 (3): 275-282.PubMedView ArticleGoogle Scholar
- Oh SK, Chen AK, Mok Y, Chen X, Lim UM, Chin A, Choo AB, Reuveny S: Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009, 2 (3): 219-230.PubMedView ArticleGoogle Scholar
- Storm MP, Orchard CB, Bone HK, Chaudhuri JB, Welham MJ: Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells. Biotechnol Bioeng. 2010, 107 (4): 683-695.PubMedPubMed CentralView ArticleGoogle Scholar
- Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E, Nanthakumar K, Woodhouse K, Husain M, Kumacheva E, et al: Generation of Human Embryonic Stem Cell-Derived Mesoderm and Cardiac Cells Using Size-Specified Aggregates in an Oxygen-Controlled Bioreactor. Biotechnology and Bioengineering. 2009, 102 (2): 493-507.PubMedView ArticleGoogle Scholar
- Roy S, Tripathy M, Mathur N, Jain A, Mukhopadhyay A: Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. European journal of haematology. 2012, 88 (5): 396-405.PubMedView ArticleGoogle Scholar
- Tsai CC, Chen YJ, Yew TL, Chen LL, Wang JY, Chiu CH, Hung SC: Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood. 2011, 117 (2): 459-469.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.